LINC02988: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC02988

NCBI ID: G105371433

LINC02988

Other Name(s): long intergenic non-protein coding RNA 2988 | Long intergenic non-protein coding RNA 2988

LINC02988: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC02988 is a long intergenic non-protein-coding RNA (lncRNA) that has been identified using RNA sequencing (RNA-seq) data. It is located on chromosome 6p21.3 and has a length of 212 nucleotides. LINC02988 is unique due to its unusual structure, as most lncRNAs are typically shorter in length. The open reading frame (ORF) of LINC02988 is 212 nucleotides long and is located between exons 1 and 2 of the gene that encodes the protein known as ITGA2B, which is a member of the intergranular protein (IGP) family.

Disease association

LINC02988 has been associated with several diseases, including cancer and neurodegenerative diseases. For example, it has been found to be downregulated in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, LINC02988 has been implicated in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

Drug targeting

LINC02988 has potential as a drug target due to its unique structure and the fact that it is located in a genomic region that has been implicated in several diseases. One approach to targeting LINC02988 is to use small molecules to alter its expression levels. This can be done by binding to specific binding sites on the RNA molecule, which can then lead to changes in local RNA levels.

Another approach to targeting LINC02988 is to use antibodies to selectively bind to the RNA molecule. This can lead to changes in the local RNA levels and potentially disrupt the normal function of the RNA molecule.

Biomarker

LINC02988 has the potential to serve as a biomarker for several diseases. For example, it can be used as a biomarker for cancer, as it is downregulated in many types of cancer. Additionally, LINC02988 can be used as a biomarker for neurodegenerative diseases, as it is implicated in these conditions.

Conclusion

LINC02988 is a long intergenic non-protein-coding RNA that has been associated with several diseases. Its unique structure and location on chromosome 6p21.3 make it a promising candidate for drug targeting and biomarker development. Further research is needed to determine the full potential of LINC02988 as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 2988

The "LINC02988 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02988 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets